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Background: Exercise electrocardiography (ECG) is frequently used in the work-up of patients with suspected
coronary artery disease (CAD), however the accuracy is reduced in women. Cardiovascular magnetic resonance
(CMR) stress testing can accurately diagnose CAD in women. To date, a direct comparison of CMR to ECG has not
been performed.
Methods and results: We prospectively enrolled 88 consecutive women with chest pain or other symptoms
suggestive of CAD. Patients underwent a comprehensive clinical evaluation, exercise ECG, a CMR stress test
including perfusion and infarct imaging, and x-ray coronary angiography (CA) within 24 hours. CAD was defined as
stenosis ≥70% on quantitative analysis of CA.
Exercise ECG, CMR and CA was completed in 68 females (age 66.4 ± 8.8 years, number of CAD risk factors 3.5 ± 1.4).
The prevalence of CAD on CA was 29%. The Duke treadmill score (DTS) in the entire group was −3.0 ± 5.4 and was
similar in those with and without CAD (−4.5 ± 5.8 and −2.4 ± 5.1; P = 0.12). Sensitivity, specificity and accuracy for
CAD diagnosis was higher for CMR compared with exercise ECG (sensitivities 85% and 50%, P = 0.02, specificities
94% and 73%, P = 0.01, and accuracies 91% and 66%, P = 0.0007, respectively). Even after applying the DTS the
accuracy of CMR was higher compared to exercise ECG (area under ROC curve 0.94 ± 0.03 vs 0.56 ± 0.07; P = 0.0001).
Conclusions: In women with intermediate-to-high risk for CAD who are able to exercise and have interpretable
resting ECG, CMR stress perfusion imaging has higher accuracy for the detection of relevant obstruction of the
epicardial coronaries when directly compared to exercise ECG.Background
Coronary artery disease (CAD) is the leading cause of
morbidity and mortality in women [1]. The assessment
of CAD in women is challenging compared with men
for several reasons. The clinical presentation is often
with atypical symptoms and the predictive power of
traditional cardiac risk factors is different in women
compared to men [2]. Based on assessment of symptoms
and risk factors, the majority of women being evaluated
for chest pain syndromes have an intermediate pre-test
probability of CAD. In this group of patients accurate
noninvasive tests are an indispensable component in the* Correspondence: Simon.Greulich@rbk.de
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reproduction in any medium, provided the ordiagnostic work-up [3]. However, well-established nonin-
vasive tests for the diagnosis of CAD all have substantial
limitations in women in predicting significant angio-
graphic CAD [4]. Furthermore, the prevalence of CAD
in women presenting with chronic anginal pain as well
as acute coronary syndromes is lower compared with
men [5,6]. Thus, based on Bayesian principles the pre-
dictive value of noninvasive tests is reduced [7]. Add-
itionally, the estimation of sensitivities and specificities
of noninvasive tests based on reported results is fre-
quently limited by post-test referral bias in which only
women with abnormal test results are referred to the
reference test, resulting in enhanced diagnostic sensitiv-
ity and diminished specificity [8].
Noninvasive diagnostic testing with exercise electro-
cardiography (ECG) is the oldest, least costly, and mostl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to be less accurate in women for the diagnosis of CAD,
and both lower sensitivities and specificities have been
reported compared to men [9,10]. This gender difference
remains even when combining the interpretation of ST-
segment deviation with exercise time and exercise
induced symptoms into the Duke Treadmill Score (DTS)
[11,12]. These difficulties posed on the clinical determin-
ation of CAD probability have led to speculation that
stress imaging approaches may be an efficient initial al-
ternative to exercise ECG in women [13], however few
data are available to support this approach.
Stress perfusion CMR has been shown previously to
accurately diagnose CAD in the clinical setting in a
mixed gender population [14] as well as in women [15].
The aim of the present study was to compare exercise
ECG (ST-segment deviation alone) and the DTS with
CMR stress testing for the detection of CAD in women
with invasive coronary angiography as the gold standard.
Methods
Study population
Women with chest pain or other signs and symptoms
suggestive of CAD, who were referred for elective coron-
ary angiography (CA) were screened for study enroll-
ment. Patients were contacted by telephone the day
before admission for scheduled angiography, and the
first patient meeting study criteria who agreed to partici-
pate was recruited. The exclusion criteria were patients
with known CAD including those with prior myocardial
infarction (MI) or revascularization procedures, as well
as contraindications to MRI (e.g. pacemaker) or adeno-
sine (e.g. high-grade AV-Block). Institutional Review
Board approval was received and written informed con-
sent was obtained from all enrolled patients. All patients
underwent x-ray angiography, exercise ECG, and CMR
within 24 hours. Some of the patients were also included
in another study [15]. However, the comparison between
stress CMR and exercise ECG is reported for the first
time for all patients included.
Protocol
On the day of study enrollment a complete medical his-
tory including responses to a Rose chest pain question-
naire was obtained. Blood samples were drawn after an
overnight fast for glucose, lipid profile, and high-sensitivity
C-reactive protein. CAD risk factors were defined using
Framingham heart study definitions [16]. A 12-lead elec-
trocardiogram was registered and scored for Q-waves and
bundle-branch block using Minnesota codes [17].
Exercise electrocardiography
All patients underwent symptom-limited cycle ergom-
eter testing with continuous 12-lead ECG monitoring. A25-Watt incremental protocol every 2 minutes was used
and a 12-lead ECG hard copy was recorded before exer-
cise and at the end of each exercise stage (every 2 min-
utes), at peak exercise and at 2-minute intervals during
recovery. Patient symptoms, rest and peak heart rate,
blood pressure, and any ECG changes were noted. The
test was discontinued for limiting symptoms (angina,
dyspnea, fatigue), abnormalities of rhythm or blood pres-
sure, or marked ST-segment deviation (>0.2 mV in the
presence of typical angina), or attainment of age-
predicted maximal heart rate (calculated as 220 – age)
[12].
All exercise ECG recordings were interpreted by con-
sensus of two experienced readers. The ECG criterion
for a positive test was greater than or equal to 1 mm of
horizontal or downsloping ST-segment deviation (de-
pression or elevation) in any lead except aVR for at least
60 to 80 milliseconds (ms) after the end of the QRS
complex, either during or after exercise. Patients with
left-bundle branch block on resting ECG, which inter-
feres with interpretation of the exercise test, were con-
sidered non-diagnostic and were not included in the
final analysis [12].
The exercise capacity in metabolic equivalents (METs)
was estimated based on patients body weight and max-
imum achieved level of exercise on the cycle ergometer
in Watts [18]. The Duke Treadmill Score (DTS) was cal-
culated based on the METs, the amount of ST-segment
deviation, and exercise angina index [12,19]. The largest
net ST-deviation, either elevation or depression in any
lead except avR was entered into the formula, if ST-
segment deviation was less than 1 mm, the value entered
was 0. Treadmill angina was graded based on the follow-
ing scale: 0 = no angina during exercise, 1 = nonlimiting
angina during exercise, and 2 = exercise-limiting angina.
The typically observed range for the DTS is −25 (highest
risk) to +15 (lowest risk), and patients were dichoto-
mized into low risk (DTS score ≥5), moderate risk (DTS
score 4 to −10), and high risk (DTS score ≤−11) groups
as previously proposed [11].
Cardiovascular magnetic resonance
Details of the CMR scan protocol and analysis have been
reported previously [14]. In brief, steady-state free-
precession cine images for assessment of LV function
were acquired in multiple short-axis (every cm through-
out the LV) and 3 long-axis views. Adenosine
(140 μgkg-1min-1) gadolinium (0.07 mmol/kg gadodia-
mide, GE Healthcare, Buckinghamshire, United King-
dom) first-pass imaging for assessment of stress
perfusion was then performed using a saturation-
recovery, single-shot, gradient-echo sequence (90˚-pre-
pulse before each slice; TE, 1.1 ms; delay time, 85–
100 ms; temporal resolution, 110–125 ms; voxel size, 3.1
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Repeated first-pass images without adenosine 15 minutes
later were performed for assessment of rest perfusion.
Five minutes after rest perfusion (additional 0.07 mmol/
kg gadodiamide), Late Gadolinium Enhancement (LGE)
imaging was performed using a segmented inversion-
recovery technique in the identical views as cine-CMR.
The image acquisition protocol was completed in about
45 minutes. A 1.5-T scanner (Siemens Sonata, Erlangen,
Germany) with a phased-array receiver coil was used.
Scans were analyzed by consensus of experienced
observers from Stuttgart (S.G.), Duke (I.K.) and Essen
(O.B.) who were blinded to patient identity, clinical in-
formation, exercise ECG and the angiography results. In
cases consensus could not be achieved an additional se-
nior observer (H.M.), also blinded to all patient informa-
tion, made the final decision. Regional parameters were
assessed using a 17-segment model as previously
described for cine and LGE [14,20]. A perfusion defect
was defined as a regional dark area, that 1) persisted for
>2 beats while other regions enhanced during the first-
pass of contrast through the LV myocardium, and 2)
involved the subendocardium. Stress and rest images
were assessed using 16 segments (segment-17 at apex
was not visualized) and each segment was scored using a
4-point scale: 0, normal; 1, probably normal; 2, probably
abnormal; 3, definitely abnormal. This scoring system
was chosen to allow dichotomization of results intoFigure 1 Outline of Patient Enrollment. CMR=Cardiovascular Magnetic
branch block.normal (≤1) and abnormal (≥2) at the same time provide
a range of scores for ROC curve analysis. Dark rim
artifact was not regarded as perfusion deficit using previ-
ously described criteria [21].
Standard methods were used to quantify left ventricu-
lar volumes (enddiastolic and endsystolic), ejection frac-
tion, and mass using Argus software (Siemens, Erlangen,
Germany) on short axis Cine images [22].
Coronary angiography and analysis by coronary artery
territory
X-ray CA was performed by standard techniques and
analyzed masked to identity, clinical information, exer-
cise ECG and CMR results. In patients with stenosis
>40% determined visually by the consensus of two
experienced cardiologists, computer-assisted quantifica-
tion of luminal diameter stenosis (QCA) was performed
(except for subtotal stenosis). Significant CAD was
defined as ≥70% narrowing of the luminal diameter in at
least one projection of at least one major epicardial ar-
tery, or ≥50% narrowing of the left main [3]. Addition-
ally, we evaluated detection of at least intermediate
grade stenoses by applying a cutoff of ≥50%.
Statistical analysis
Continuous data are expressed as mean ± standard devi-
ation. Comparisons between groups were made using
two sample t tests for continuous data and χ2 tests forResonance, ECG= exercise electrocardiography, LBBB= left bundle-
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assumptions of the χ2 test were not met. The McNemar
test was used to compare sensitivities, specificities and
the diagnostic accuracy of CMR and exercise ECG. The
receiver-operator characteristic (ROC) curve analyses
was performed to compare the diagnostic performance
of the CMR and exercise ECG. Statistical tests were 2-
tailed; P< 0.05 was considered statistically significant.
Results
Study population
A total of 88 women were enrolled in the study from
September 2004 to December 2005 (Figure 1). Eight
women did not have a complete CMR test. In one case
scanner operator error lead to incomplete data, one pa-
tient requested to stop the scan due to discomfort in the
scanner. In 6 cases, imaging was omitted because of
non-CMR related issues: one had xanthines in the morn-
ing before the scan; one had beta blockers within 12
hours before the scan; one withdrew consent; in two,
intravenous access could not be obtained; and in one,
there was severe adenosine-induced dyspnea which led
to early termination of the protocol. The woman with
dyspnea, which quickly resolved after stopping adeno-
sine, had the only adverse event during stress-testing. In
twelve women the exercise ECG could not be completed
or was non-diagnostic: four women had left bundle-
branch block, two refused exercising and withdrew con-
sent from study participation, in three the ECG docu-
mentation was of inadequate quality for interpretation,
three women were sent to cardiac catheterization before
the research exercise test could be performed due to
clinical workflow constraints. The remaining 68 patients,
who underwent both an exercise ECG and stress CMR
were included in the final analysis.
Table 1 summarizes the patient characteristics. The
majority (61%) had angina by Rose chest pain question-
naire, however the proportion of women with angina
was similar in the groups with and without obstructive
CAD (p = 0.45). Patients had several CAD risk factors
(3.5 ± 1.4), but the prevalence of CAD risk factors was
similar in women with CAD and those without CAD.
The only differences noted were older age and higher
prevalence of hyperlipidemia in females with CAD. Only
2 women were pre-menopausal, all others were post-
menopausal. The mean body mass index was
27.3 ± 4.6 kg/m2 in the entire group, and was similar in
both women with (27.2 ± 3.6 kg/m2) and without CAD
(27.4 ± 5.0 kg/m2; P = 0.88). The majority (79%) had an
abnormal noninvasive stress-test as part of their clinical
workup prior to elective CA, in 14 patients (21%) symp-
toms alone were considered highly suggestive of CAD
by the treating physician and CA was deemed indicated
without a preceding noninvasive test.Exercise ECG
The exercise ECG test results are shown in Table 2.
There was no significant difference in heart-rate and
blood-pressure response in women with or without
CAD. Overall, the exercise duration was 5.4 ± 1.9 min
and maximum achieved level of exercise capacity was
6.0 ± 1.5 METs. Women with CAD did achieve similar
exercise times and METs as women without CAD. The
occurrence of exercise-induced angina was similar
among women with and without CAD. Among the 16
women who developed angina during exercise (both ex-
ercise limiting and non-limiting angina), 8 (50%) had
CAD on CA. Conversely, among the fifty women with-
out angina during exercise 11 (22%) had CAD (P = 0.08).
In two patients, symptoms were not documented. Target
heart rate (THR), calculated as ≥85% of age-predicted
maximal heart rate, was reached in 49 (72%) of studies.
The percentage of patients who reached THR was simi-
lar in women with and without CAD. In women who
reached the THR the sensitivity, specificity, and accuracy
were 43%, 74%, and 65% for detection of CAD (≥70%),
whereas in women not reaching THR the sensitivity,
specificity, and accuracy were 67%, 69%, and 68%, re-
spectively. Of the 19 women not reaching THR, 7
patients developed angina (4 of which had CAD) and
the remaining 12 women developed either fatigue, dys-
pnea, or other non-anginal symptoms during exercise.
The DTS was −3.0 ± 5.4 in the entire cohort, and was
similar in the women with and without CAD (−4.5 ± 5.8
vs. -2.4 ± 5.1; p = 0.12). The majority of women (n = 56)
were in the moderate risk category by the DTS, 16 (29%)
of these were diagnosed with CAD on CA. Four (6%)
women each were in the low-risk and high-risk groups
by the DTS. CAD was present in 1 woman in the low-
risk group and in 2 women in the high-risk group.Stress CMR
The infusion duration for adenosine was 3.2 ± 0.5 min-
utes. The heart-rate was 73.2 ± 12.0 beats/min at rest
and 97.6 ± 14.4 beats/min at peak stress. The majority
(82%) experienced symptoms during adenosine infu-
sion; most frequent symptoms were dyspnea and chest
discomfort described as pain, pressure, tightness or
burning, followed by head pressure, flush, nausea, and
neck discomfort. Among the 68 women who com-
pleted imaging, five had frequent ventricular ectopy
and one had atrial fibrillation chronically and during
imaging. All 68 were considered to have evaluable
images and were included in the analysis. Table 3
shows the results of quantitative analysis of cardiac
volumes and function. Overall, left ventricular ejection
fraction was preserved (65.9 ± 10.1%) with normal car-
diac volumes.
Table 1 Baseline Characteristics
Characteristic Entire Group(n=68) CAD *(n=20) No CAD(n=48) P
Age (yrs) 66.4±8.8 70.8±5.9 64.5±9.2 0.001
CAD risk factors
Diabetes 16 (24%) 5 (25%) 11 (23%) 0.85
Hypertension 45 (66%) 16 (80%) 29 (60%) 0.12
Cigarette smoking 21 (30%) 5 (25%) 16 (33%) 0.50
Hyperlipidemia 41 (60%) 18 (90%) 23 (48%) 0.001
Family history of CAD 33 (49%) 9 (45%) 24 (50%) 0.71
Menopause 66 (97%) 20 (100%) 46 (96%) 0.35
Obesity (BMI ≥ 30 kg/m2) 19 (28%) 6 (30%) 13 (27%) 0.81
Number of risk factors 3.5±1.4 4.0±1.2 3.4±1.5 0.13
Rose chest pain questionnaire
Angina 41 (61%) 13 (68%) 28 (58%) 0.45
Medications
Statins 20 (29%) 8 (40%) 12 (25%) 0.22
Beta-blockers 35 (51%) 14 (70%) 21 (44%) 0.05
Aspirin 43 (63%) 15 (75%) 28 (58%) 0.19
ACE-inhibitors 27 (40%) 8 (40%) 19 (40%) 0.97
Nitrates 7 (10%) 2 (10%) 5 (10%) 1.00††
Diuretics 19 (28%) 3 (15%) 16 (33%) 0.12
Hormone replacement† 32 (48%) 8 (40%) 24 (52%) 0.41
Blood tests {
Fasting glucose (mg/dL) 99.3±16.6 101.7±15.6 98.4±17.1 0.52
Lipids
Total cholesterol (mg/dL) 225.3±36.8 237.6±33.8 220.2±37.2 0.08
LDL (mg/dL) 137.0±32.5 147.3±28.5 132.7±33.4 0.09
HDL (mg/dL) 59.8±16.8 59.9±19.6 59.7±15.6 0.97
Triglycerides (mg/dL) 146.7±70.0 152.3±71.1 144.4±70.2 0.68
hs-CRP (mg/dL) 0.36±0.5 0.48±0.7 0.32±0.4 0.35
Indication for angiography
Positive stress nuclear study 9 (13%) 5 (25%) 4 (8%)
Positive stress echo study 6 (9%) 3 (15%) 3 (6%)
Positive treadmill ECG study 39 (57%) 9 (45%) 30 (63%)
Clinical symptoms alone 14 (21%) 3 (15%) 11 (23%)
12-lead ECG
Q-wave || 5 (7%) 1 (5%) 4 (8%) 1.00††
RBBB # 2 (3%) 1 (5%) 1 (2%) 1.00††
CAD = coronary artery disease, BMI = body mass index, ACE-inhibitor = angiotensin-converting-enzyme inhibitor, LDL = low density lipoprotein, HDL = high
density lipoprotein, hs-CRP = high-sensitivity C-reactive protein, RBBB = right bundle branch block.
* CAD defined by x-ray coronary angiography (see text).
† Current or ever-users (peri- or postmenopausal women).
{ Blood tests were acquired within 24 hours of CMR in 54 patients for fasting glucose (non-diabetic patients only).
|| Minnesota codes 1-1-1 to 1-2-7.
# Minnesota codes 7-2-1 and 7-2-2.
†† Fisher exact test (two-tailed).
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CAD (≥70%) on CA was found in 20 (29%) women, and
26 (38%) women had stenosis ≥50%. The diagnostic per-
formance of CMR and exercise ECG according to CAD
severity is shown in Tables 4 and 5. CMR stress testing(including LGE, according to the diagnostic algorithm
proposed by Klem at al [14].) had higher sensitivity (85%
vs 50%; P = 0.02), higher specificity (94% vs 73%;
P = 0.01), and higher diagnostic accuracy (91% vs 66%;
P = 0.0007) compared with exercise ECG. Eight women
Table 2 Exercise ECG Test Results
Parameter Entire Group(n=68) CAD†(n=20) No CAD(n=48) P
Rest HR (beats/min) 76.9±13.4 72.5±11.9 78.7±13.7 0.08
Rest SBP (mmHg) 127.0±20.6 128.5±18.6 126.4±21.5 0.71
Rest DBP (mmHg) 82.7±11.6 85.8±12.9 81.3±10.9 0.15
Peak HR (beats/min) 136.7±19.1 134.4±18.3 137.7±19.5 0.52
Peak SBP (mmHg) 188.0±28.7 185.4±16.8 189.1±32.6 0.54
Peak DBP (mmHg) 88.9±16.4 91.7±13.2 87.7±17.6 0.37
Exercise duration (min) 5.4±1.9 5.3±1.6 5.4±2.1 0.76
THR reached 49 (72%) 14 (70%) 35 (73%) 0.81
METs 6.0±1.5 5.8±1.1 6.0±1.7 0.62
DTS −3.0±5.4 −4.5±5.8 −2.4±5.1 0.12
ECG = electrocardiogram, CAD = coronary artery disease, HR = heart rate, SBP = systolic blood pressure, DBP = diastolic blood pressure, THR = 85% of age-
predicted maximum heart rate, METs = metabolic equivalents, DTS = Duke Treadmill Score,
† CAD defined by x-ray coronary angiography (see text).
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women and exercise ECG detected four women. Even
after considering clinical information (exercise capacity
and symptoms) in addition to ST-segment response in
the DTS, the accuracy of CMR was higher compared to
exercise ECG (area under ROC curve 0.94 ± 0.03 vs
0.56 ± 0.07; P = 0.0001, Figure 2). The combined results
of CMR and exercise ECG in all patients are shown in
Figure 3. Overall, CMR and exercise ECG were concord-
ant in 43 (63%) patients and discordant in 25 patients.
Among the patients with discordant results, 14 had a
positive exercise ECG and a negative CMR. In 13 (93%)
of those patients no obstructive CAD was found on CA.
The remaining patient (1/14 = 7%) had a mid LAD sten-
osis of 60-70% by visual analysis, which was graded 72%
by QCA. In this patient no intervention was performed
and no adverse event occurred during more than 3 years
of follow-up. Conversely, 11 patients had a negative ex-
ercise ECG and a positive CMR. In 8 (73%) of those
patients, significant CAD was found on CA.
Discussion
The major finding of the present study was that perfu-
sion CMR has a higher accuracy for the detection of
CAD when directly compared to exercise ECG inTable 3 Quantitative Cine CMR Results
Parameter Entire Group(n=68)




LV-EDV Index (ml/m2) 53.6±12.1
LV-ESV Index (ml/m2) 18.8±9.4
LV-mass Index (gm/m2) 58.3±12.4
CMR = cardiovascular magnetic resonance, CAD = coronary artery disease, LV = left
† CAD defined by x-ray coronary angiography (see text).women who are capable of maximal exercise and have
an interpretable resting ECG. The sensitivity of 85% and
specificity of 94% with CMR was obtained in symptom-
atic women with intermediate-to-high risk for CAD. We
minimized pre-test referral bias by excluding patients
with known CAD (or prior MI) and normal studies.
Post-test referral bias was minimized in that all patients
underwent the reference test (coronary angiography) in-
dependent of the results of both exercise ECG and
CMR. Both noninvasive tests were performed for re-
search purposes only, and did not affect patient
management.
Exercise ECG is considered the initial test of choice in
women with suspected CAD [3], which is based on a
large number of studies demonstrating its utility for the
detection of CAD. In a meta-analysis including 19 exer-
cise ECG studies with 3721 women the mean sensitivity
was 61%, and mean specificity was 70%. However, a wide
range of sensitivities (27%-91%) and specificities (46-
86%) was observed in the individual studies, which is
largely attributed to differences in prevalence of CAD
(ranging from 18% to 75%), different influence by post-
test referral bias, and different thresholds for interpret-
ing a test as positive [10]. The sensitivity and specificity








ventricle, EDV = end-diastolic volume, ESV = end-systolic volume.
Table 4 Diagnostic Performance of CMR Stress Testing for
the Detection of CAD According to Disease Severity
CMR Stress Test
CAD ≥ 70%* CAD ≥ 50%
Sensitivity 85% (17/20) 65% (17/26)
Specificity 94% (45/48) 93% (39/42)
Diagnostic Accuracy 91% (62/68) 82% (55/68)
PPV 85% (17/20) 85% (17/20)
NPV 94% (45/48) 81% (39/48)
CMR = Cardiovascular Magnetic Resonance, CAD = Coronary Artery Disease,
PPV = Positive Predictive Value, NPV = Negative Predictive Value.
* or ≥50% left main disease.
Figure 2 Receiver-Operator Characteristic Curves. Receiver-
operator characteristic curve analyses comparing CMR and the Duke
Treadmill Score for the detection CAD in all patients. The diagnostic
accuracy of CMR was significantly greater than the Exercise ECG
even when considering the Duke Treadmill Score (P = 0.0001).
AUC= area under the curve.
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undergoing exercise ECG with a sensitivity of 47% and
specificity of 73% [23].
Stress perfusion CMR is a relatively new noninvasive
method with high diagnostic accuracy for the diagnosis of
CAD, which has been demonstrated in various patient
populations [24]. Few studies have assessed the utility of
CMR stress testing specifically in women [15,25-27]. The
prior reports vary in imaging technology (older pulse
sequences and different coil technology) [25], pre-test
probability (patients with known CAD and prior MI
included) [26], and CAD prevalence (low-risk ED patients
with chest pain) [27]. The sensitivities and specificities in
the previous studies ranged from 57%-95% and 75%-100%,
which concurs with our results. None of the prior reports
however, directly compared the diagnostic performance of
CMR to exercise ECG in the same patients.
Exercise ECG is the oldest noninvasive test for evalu-
ation of patients with chest pain, it is simple, widely avail-
able, relatively inexpensive, and there is substantial
experience with this test. However, this test is considered
less accurate in women compared with men. Reduced sen-
sitivity has been attributed to lower prevalence of CAD
and the inability of many women to exercise to maximum
aerobic capacity [9,28,29]. Exercise ECG is generally con-
sidered also as less specific in women than in men even
after correction for post-test referral bias [30]. Among theTable 5 Diagnostic Performance of Exercise ECG for the
Detection of CAD According to Disease Severity
Exercise ECG
CAD ≥ 70%* CAD ≥ 50%
Sensitivity 50% (10/20) 50% (13/26)
Specificity 73% (35/48) 76% (32/42)
Diagnostic Accuracy 66% (45/68) 66% (45/68)
PPV 44% (10/23) 57% (13/23)
NPV 78% (35/45) 71% (32/45)
CMR = Cardiovascular Magnetic Resonance, ECG = Electrocardiogram.
CAD = Coronary Artery Disease, PPV = Positive Predictive Value.
NPV = Negative Predictive Value.
* or ≥50% left main disease.non-Bayesian factors, syndrome X, differences in micro-
vascular function, and possibly hormonal differences have
been discussed [12,31]. Current guidelines recognize the
limitations in accuracy of exercise ECG and that stress-
imaging approaches in general may be an efficient initial
alternative in women. However, presently available data
concerning direct comparison of exercise ECG to stress
imaging tests in the same patient is insufficient to justify
routine stress imaging as the initial test for CAD in
women [12]. CMR has emerged as an attractive new non-
invasive test with an improved spatial resolution com-
pared to nuclear techniques without the use of ionizing
radiation. However, availability is limited to expert centers
and the cost compared to exercise ECG is relatively high.
The present study is a first step to investigate comparative
effectiveness between exercise ECG and CMR stress test-
ing by directly comparing results of both studies in the
same populations.
Limitations of the present study are that not all poten-
tial sources of pretest referral bias were removed be-
cause patients were selected from those already
scheduled for invasive angiography. In addition, invasive
CA is not necessarily the ideal gold-standard for com-
parison as functional significance of coronary obstruc-
tion and luminal diameter stenosis are moderately
correlated. Furthermore it is important to keep in mind
that the algorithm used for CMR analysis [14] is
intended to detect significant obstruction of the epicar-
dial coronaries compared to invasive CA (e.g. >70%
stenosis). Thus, perfusion defects that were regarded as
Figure 3 Combined Outcome of Exercise ECG and CMR For the Detection of CAD. ECG= Exercise Electrocardiogram, CMR=Cardiovascular
Magnetic Resonance, CAD=Coronary Artery Disease.
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analysis may in fact represent microvascular dysfunction.
Since microvascular dysfunction is hardly detectable by
conventional invasive CA these patients were regarded
as “healthy” by CA, and correctly identified as such by
CMR explaining the high specificity, despite the possible
presence of microvascular dysfunction responsible for
the clinical complaints of these women. Therefore, add-
itional data with regard to the role of microvascular dys-
function is needed to fully understand the diagnostic
performance of CMR in the setting of women with chest
pain or other signs and symptoms suggestive of CAD.
The present study did also not include a comprehen-
sive cost-comparison. A lower cost of the exercise ECG
test however, does not necessarily translate into lower
overall cost of patient care, because the sum of the cost
of additional downstream testing and interventions may
be higher when the initial exercise ECG is less accurate
than CMR imaging test [32]. Cost analysis poses several
challenges. The cost of a false positive ECG results is
readily quantifiable by the cost of unnecessary cardiac
catheterization. However, the cost of a false negative test
is more difficult to quantify as it involves not only cost
associated with morbidity (hospitalization, procedures)
but also cost related to mortality, which is much more
difficult to quantify.
Conclusion
The present study demonstrates that in women with
intermediate-to-high risk for CAD who are able to exer-
cise and have interpretable resting ECG, CMR stresstesting has higher accuracy for the detection of relevant
obstruction of the epicardial coronaries. These findings
warrant further investigations to evaluate both accuracy
as well as cost to justify CMR stress testing as the initial
test in this population.
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